Company news
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. news in 2020
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2020, newest first.
Shenzhen Hepalink Pharmaceutical Group: "Enoxaparin sodium injection" obtains approval from FDA
September 21, 2020
Change of joint company secretary and authorized representative and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules
September 18, 2020
Change of principal place of business in hong kong
September 11, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces 2020 Interim Results
August 30, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces Exciting Regulatory Developments
June 28, 2020
Shenzhen Hepalink Pharmaceutical Group: Hepalink Announces the Appointment of Healthcare Senior Executive Mr. Frank Sun as Executive Director and Vice Chairman of the Board
March 5, 2020